Business FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV by news 09/06/2023 written by news 09/06/2023 If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV.source 0 comment 0 FacebookTwitterPinterestEmail news previous post Oura launches new social, sleep features as health tracker market continues to grow next post Stock Clearinghouse to Suspend Data Feed Criticized for Leaking Trading Info Related Posts Why Few Bond Funds Are Passively Managed—and How... 08/12/2024 'It’s an old person's drink.' Is Britain's love... 08/12/2024 Harland & Wolff close to government-backed rescue deal... 08/12/2024 Young Men Are Making Risky Bets on Crypto... 08/12/2024 Bitcoin surges past $100k for first time 08/12/2024 US jobs bounce back after hurricanes and strikes 08/12/2024